Clinical Trial Update: Pharmacokinetic Study to Evaluate Anti-mycobacterial Activity of TMC207 in Combination With Background Regimen (BR) of Multidrug Resistant Tuberculosis (MDR-TB) Medications for Treatment of Children/Adolescents With Pulmonary MDR-TB [Phase 2]

View source ↗

Summary

Phase 2 pharmacokinetic study evaluating bedaquiline (TMC207) in combination with a background MDR-TB regimen for treating children/adolescents with pulmonary m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis Multidrug-resistant

Drugs mentioned

• bedaquiline (bedaquiline)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Tuberculosis, Multidrug-Resistant | Phase 2 | Status: RECRUITING